Schifferli Alexandra, Cavalli Franco, Godeau Bertrand, Liebman Howard A, Recher Mike, Imbach Paul, Kühne Thomas
Department of Hematology/Oncology, University Children's Hospital Basel, Basel, Switzerland.
Intercontinental Cooperative Immune thrombocytopenia (ITP) Study Group, Basel, Switzerland.
Front Med (Lausanne). 2021 Jun 24;8:613192. doi: 10.3389/fmed.2021.613192. eCollection 2021.
The pathogenesis of immune thrombocytopenia (ITP) is increasingly being elucidated, and its etiology is becoming more frequently identified, leading to a diagnostic shift from primary to secondary ITP. The overlap between autoimmunity, immunodeficiency, and cancer is evident, implying more interdisciplinarity in daily care. This mini-review is based on an expert meeting on ITP organized by the Intercontinental Cooperative ITP Study Group and presents the challenges of hematologists in understanding and investigating "out of the box" concepts associated with ITP.
免疫性血小板减少症(ITP)的发病机制正日益明晰,其病因也越来越多地被确定,这导致诊断从原发性ITP向继发性ITP转变。自身免疫、免疫缺陷和癌症之间的重叠很明显,这意味着在日常护理中需要更多的跨学科知识。本小型综述基于洲际合作性ITP研究组组织的一次关于ITP的专家会议,介绍了血液科医生在理解和研究与ITP相关的“跳出框框”概念时所面临的挑战。